학술논문
Efficacy of the adjuvanted subunit protein COVID-19 vaccine, SCB-2019: a phase 2 and 3 multicentre, double-blind, randomised, placebo-controlled trial
Document Type
Article
Author
Bravo, L.; Smolenov, I.; Han, H.H.; Li, P.; Hosain, R.; Baccarini, C.; Hu, B.; Rockhold, F.; Clemens, S.A.C.; Roa, C.; Borja-Tabora, C.; Quinsaat, A.; Lopez, P.; López-Medina, E.; Brochado, L.; Hernández, E.A.; Reynales, H.; Medina, T.; Velasquez, H.; Toloza, L.B.; Rodriguez, E.J.; de Salazar, D.I.M.; Rodríguez, C.A.; Sprinz, E.; Cerbino-Neto, J.; Luz, K.G.; Schwarzbold, A.V.; Paiva, M.S.; Carlos, J.; Salvani-Bautista, M.; Montellano, M.E.B.; de Los Reyes, M.R.A.; Yu, C.Y.; Alberto, E.R.; Panaligan, M.M.; Buntinx, E.; Hites, M.; Martinot, J.-B.; Bhorat, Q.E.; Badat, A.; Jurgens, J.; Engelbrecht, J.; Ambrosino, D.; Richmond, P.; Siber, G.; Liang, J.; Clemens, R.
Source
In: The Lancet . (The Lancet, 29 January 2022, 399(10323):461-472)
Subject
Language
English
ISSN
1474547X
01406736
01406736